UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Special]‘K-Medi’s overseas advance will contribute to health of global citizens’
The Division of Global Health Care Affairs at the Ministry of Health and We...
by Kwak Sung-sun
|
2019-04-19 14:22
라인
[Special]‘We hope entire world will experience K-Care’
The Division of Global Health Care at the Ministry of Health and Welfare wa...
by Kwak Sung-sun
|
2019-04-09 11:32
라인
[Special] Interleukin inhibitors Cosentyx, Taltz target psoriasis market
Interleukin inhibitors are rising as the newest psoriasis treatment.Tumor n...
by Kim Yun-mi
|
2019-03-26 14:56
라인
[Special]Environment against childbirth, rearing causes sexual discrimination
Doctors cited two reasons sexual discrimination do not disappear – ch...
by Song Soo-youn
|
2019-03-20 09:43
라인
[Special]Female doctors suffer from discrimination at hospitals just because they are 'women'
Female doctors are experiencing discriminations throughout the medical comm...
by Song Soo-youn
|
2019-03-19 11:14
라인
[Special] PCSK9 inhibitors aim to replace statin in cholesterol reduction
Amgen's dyslipidemia treatment Repatha (right) and Sanofi's Praluen...
by Kim Yun-mi
|
2019-03-18 15:49
라인
[Special] Female doctors suffer discrimination from moment of selecting medical residents
The medical community was not an exception to sexual discrimination. Four o...
by Song Soo-youn
|
2019-03-15 10:24
-
1
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top